High proportions of post-exertional malaise and orthostatic intolerance in people living with post-COVID-19 condition: the PRIME post-COVID study

Author:

Pagen Demi M. E.ORCID,Herck Maarten VanORCID,van Bilsen Céline J. A.,Brinkhues StephanieORCID,Konings Kevin,den Heijer Casper D. J.,Spruit Martijn A.,Hoebe Christian J. P. A.,Dukers-Muijrers Nicole H. T. M.ORCID

Abstract

AbstractBackgroundExercise-based treatments can be harmful in people who were SARS-CoV-2 positive and living with post-COVID-19 condition (PL-PCC) and who have post-exertional malaise (PEM) or orthostatic intolerance (OI). Nevertheless, PEM and OI are not routinely assessed by clinicians. We estimated PEM and OI proportions in PL-PCC, as well in people not living with PCC (PnL-PCC) and negatives (i.e., never reported a SARS-CoV-2 positive test), and identified associated factors.MethodsParticipants from the PRIME post-COVID study were included. PEM and OI were assessed using validated questionnaires. PCC was defined as feeling unrecovered after SARS-CoV-2 infection. Multivariable regression analyses to study PEM and OI were stratified for sex.ResultsData from 3,783 participants was analyzed. In PL-PCC, proportion of PEM was 48.1% and 41.2%, and proportion of OI was 29.3% and 27.9% in women and in men, respectively. Proportions were higher in PL-PCC compared to negatives, for PEM in women OR=4.38 [95%CI:3.01-6.38]; in men OR=4.78 [95%CI:3.13-7.29]; for OI in women 3.06 [95%CI:1.97-4.76]; in men 2.71 [95%CI:1.75-4.21]. Associated factors were age ≤60 years, ≥1 comorbidities and living alone.ConclusionsHigh proportions of PEM and OI are observed in PL-PCC. Standard screening for PEM and OI is recommended in PL-PCC, to promote appropriate therapies.Trial registration ClinicalTrials.gov identifier:NCT05128695

Publisher

Cold Spring Harbor Laboratory

Reference32 articles.

1. What is the best way to treat post COVID-19 condition (long COVID)? Researchers in Belgium are trying to develop the answer: World Health Organization; [updated 14-03-2023. Available from: https://www.who.int/europe/news/item/14-03-2023-what-is-the-best-way-to-treat-a-complex-new-disease-like-post-covid-19-condition-(long-covid)-researchers-in-belgium-are-developing-the-answer.

2. Crook H , Raza S , Nowell J , Young M , Edison P. Long covid—mechanisms, risk factors, and management. bmj. 2021;374.

3. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact;EClinicalMedicine,2021

4. Komaroff AL , Bateman L . Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Frontiers in Medicine. 2021:1132.

5. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)—A Systemic Review and Comparison of Clinical Presentation and Symptomatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3